18F-FSPG

DRUG4 trials

Sponsors

Life Molecular Imaging SA, Andrei Iagaru, Stanford University, M.D. Anderson Cancer Center

Conditions

B-Cell NeoplasmBrain CancerCardiac SarcoidosisEstrogen Receptor NegativeHER2/Neu NegativeHead and Neck CancerHead and Neck Squamous Cell CarcinomaMetastatic Renal Cell Cancer

Early Phase 1

A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma

TerminatedNCT05322135

M.D. Anderson Cancer CenterHead and Neck Cancer, Head and Neck Squamous Cell Carcinoma

Start: 2022-09-14End: 2025-03-07Updated: 2025-04-09

Phase 1

PET Imaging of Intracranial Cancers With 18F-FSPG

TerminatedNCT02370563

Life Molecular Imaging SABrain Cancer

Start: 2014-11-30End: 2016-03-31Updated: 2016-09-02

Phase 2

18F-FSPG PET/CT for Cancer Patients on Therapy

CompletedNCT02599194

Andrei IagaruB-Cell Neoplasm, Estrogen Receptor Negative, HER2/Neu Negative +13

Start: 2015-07-31End: 2016-12-14Updated: 2019-01-03

18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation

TerminatedNCT03103490

Stanford UniversityCardiac Sarcoidosis, Myocardial Inflammation

Start: 2017-08-02End: 2021-09-28Updated: 2023-04-07

Related Papers

<sup>18</sup>F-FSPG PET/CT Imaging of System x<sub>C</sub><sup>–</sup> Transporter Activity in Patients with Primary and Metastatic Brain Tumors

Radiology2022-02-2217 citations